Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Cameron

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Genetics and Metabolism|July 28, 2010
Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domainThea Bismo Strøm, Øystein L Holla, Kristian Tveten, et al.
Molecular Genetics and Metabolism|November 15, 2011
Characterization of a naturally occurring degradation product of the LDL receptorKristian Tveten, Thea Bismo Strøm, Jamie Cameron, et al.
Human Molecular Genetics|March 31, 2006
Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsJamie Cameron, Øystein L Holla, Trine Ranheim, et al.
Biochemical and Biophysical Research Communications|May 3, 2011
The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradationThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Biochemical and Biophysical Research Communications|November 15, 2011
Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Atherosclerosis|November 22, 2008
Mutation S462P in the PCSK9 gene reduces secretion of mutant PCSK9 without affecting the autocatalytic cleavageJamie Cameron, Øystein L Holla, Jon K Laerdahl, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2012
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathwaysJamie Cameron, Martin P Bogsrud, Kristian Tveten, et al.
Biochemical and Biophysical Research Communications|February 18, 2011
Removal of acidic residues of the prodomain of PCSK9 increases its activity towards the LDL receptorØystein L Holla, Jon K Laerdahl, Thea Bismo Strøm, et al.
The FEBS Journal|July 18, 2008
Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusionJamie Cameron, Øystein L Holla, Knut Erik Berge, et al.
Journal of Lipid Research|July 21, 2011
Role of the C-terminal domain of PCSK9 in degradation of the LDL receptorsØystein L Holla, Jamie Cameron, Kristian Tveten, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Genetics and Metabolism|July 28, 2010
Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domainThea Bismo Strøm, Øystein L Holla, Kristian Tveten, et al.
Molecular Genetics and Metabolism|November 15, 2011
Characterization of a naturally occurring degradation product of the LDL receptorKristian Tveten, Thea Bismo Strøm, Jamie Cameron, et al.
Human Molecular Genetics|March 31, 2006
Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsJamie Cameron, Øystein L Holla, Trine Ranheim, et al.
Biochemical and Biophysical Research Communications|May 3, 2011
The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradationThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Biochemical and Biophysical Research Communications|November 15, 2011
Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Atherosclerosis|November 22, 2008
Mutation S462P in the PCSK9 gene reduces secretion of mutant PCSK9 without affecting the autocatalytic cleavageJamie Cameron, Øystein L Holla, Jon K Laerdahl, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2012
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathwaysJamie Cameron, Martin P Bogsrud, Kristian Tveten, et al.
Biochemical and Biophysical Research Communications|February 18, 2011
Removal of acidic residues of the prodomain of PCSK9 increases its activity towards the LDL receptorØystein L Holla, Jon K Laerdahl, Thea Bismo Strøm, et al.
The FEBS Journal|July 18, 2008
Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusionJamie Cameron, Øystein L Holla, Knut Erik Berge, et al.
Journal of Lipid Research|July 21, 2011
Role of the C-terminal domain of PCSK9 in degradation of the LDL receptorsØystein L Holla, Jamie Cameron, Kristian Tveten, et al.
Pageof 3